, ,

As biosimilars become more of our treatment landscape, we’re learning more about how patient (and physician) education has on the perceived effect of these new medications. A nocebo effect (unlike a “placebo”) is when a patient has a negative view of the treatment which impacts the outcome. The nocebo effect is showing up with biosimilars. Read more about this in my article for rheumatoidarthritis.net here: